Correlation Between Aslan Pharmaceuticals and Compass Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aslan Pharmaceuticals and Compass Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aslan Pharmaceuticals and Compass Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aslan Pharmaceuticals and Compass Therapeutics, you can compare the effects of market volatilities on Aslan Pharmaceuticals and Compass Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aslan Pharmaceuticals with a short position of Compass Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aslan Pharmaceuticals and Compass Therapeutics.
Diversification Opportunities for Aslan Pharmaceuticals and Compass Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Aslan and Compass is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals and Compass Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Therapeutics and Aslan Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aslan Pharmaceuticals are associated (or correlated) with Compass Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Therapeutics has no effect on the direction of Aslan Pharmaceuticals i.e., Aslan Pharmaceuticals and Compass Therapeutics go up and down completely randomly.
Pair Corralation between Aslan Pharmaceuticals and Compass Therapeutics
If you would invest 164.00 in Compass Therapeutics on September 1, 2024 and sell it today you would lose (1.00) from holding Compass Therapeutics or give up 0.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Aslan Pharmaceuticals vs. Compass Therapeutics
Performance |
| Timeline |
| Aslan Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Compass Therapeutics |
Aslan Pharmaceuticals and Compass Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aslan Pharmaceuticals and Compass Therapeutics
The main advantage of trading using opposite Aslan Pharmaceuticals and Compass Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aslan Pharmaceuticals position performs unexpectedly, Compass Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Therapeutics will offset losses from the drop in Compass Therapeutics' long position.| Aslan Pharmaceuticals vs. Monte Rosa Therapeutics | Aslan Pharmaceuticals vs. NewAmsterdam Pharma | Aslan Pharmaceuticals vs. Inventiva Sa | Aslan Pharmaceuticals vs. Cullinan Oncology LLC |
| Compass Therapeutics vs. Ideaya Biosciences | Compass Therapeutics vs. AnaptysBio | Compass Therapeutics vs. MeiraGTx Holdings PLC | Compass Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |